” Since the new year drug companies in the United Kingdom have begun recording any payments they make to doctors for certain services, such as chairing a meeting, in advance of plans to disclose the data to the public. This move echoes similar initiatives in the United States and the Netherlands designed to bring transparency to financial relationships between doctors, teaching hospitals, and drug companies. The information gathered over the next 12 months, and in subsequent years, will be uploaded to a publicly searchable database due to launch in July 2016… ”
Continue reading New year brings new transparency for drug company payments to doctors in UK, BMJ 2015;350:g7748.
Find more information about Disclosure of payments to individual healthcare professionals and Individual disclosure on the abpi website.